首页> 外国专利> Hydroxy-ethyl-tetrahydro-(1,4)-oxazine derivs. - whose quaternary salts are antispasmodics for treatment of vascular, digestive and bronchial smooth muscle spasmodic syndromes

Hydroxy-ethyl-tetrahydro-(1,4)-oxazine derivs. - whose quaternary salts are antispasmodics for treatment of vascular, digestive and bronchial smooth muscle spasmodic syndromes

机译:羟基-乙基-四氢-(1,4)-恶嗪衍生物。 -其季盐对血管痉挛,消化道和支气管平滑肌痉挛综合症具有镇痉作用

摘要

2-(2-Hydroxyethyl)-tetrahydro-1,4-oxazines of formula (III) and their quat. ammonium derivs., with R1X (IV) are novel cpds. (where Ar, Ar1 independently = opt. halo substd. aromatic residues, R, R1 independently = 1-4C alkyl and X = an anion of the type Cl-, Br-, I- or CH3SO4-). (IV) are spasmolytics esp. useful for treatment of spasmodic syndromes of smooth muscle or vascular, digestive and bronchial origin, anticholinergics and musculostropics and (III) are intermediates in their preparation. They are administered by usual routes in daily doses of 10-500 mg. A typical prod. is 2-(2,2-diphenyl-2-hydroxyethyl)-4-methyl-tetrahydro-1,4-oxazine prepd. from 2-cyanomethyl-4-methyl-tetrahydrooxazine via the 2-carbethoxymethyl deriv. and reaction with phenylmagnesium bromide. The product may be reacted with methyl bromide to form the quaternary salt.
机译:式(III)的2-(2-羟乙基)-四氢-1,4-恶嗪及其季铵盐。具有R1X(IV)的铵衍生物是新颖的cpds。 (其中Ar,Ar1独立地=被卤素取代的优选的卤素残基,R,R1独立地= 1-4C烷基,X = Cl-,Br-,I-或CH 3 SO 4-型的阴离子)。 (IV)是解痉药。可用于治疗平滑肌或血管痉挛综合征,消化道和支气管起源的抗胆碱能药和促肌肉药,(III)是其制备的中间体。它们通过常规途径以每天10-500 mg的剂量给药。一个典型的产品。是2-(2,2-二苯基-2-羟乙基)-4-甲基-四氢-1,4-恶嗪制备。由2-氰基甲基-4-甲基-四氢恶嗪通过2-碳乙氧基甲基衍生物得到。与苯基溴化镁反应。产物可以与甲基溴反应形成季盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号